Regulation A · Tier 2 · AIBT
Aibotics, Inc.
Aibotics, Inc. (AIBT) filed a Tier 2 Regulation A offering statement (Form 1-A) on Jan 6, 2022 for up to $15M at $10.00 per security. The SEC qualified the offering on Jan 18, 2022.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $15M
- Offer price
- $10.00
- Security type
- Equity (common or preferred stock)
- Filed
- Jan 6, 2022
- Qualified
- Jan 18, 2022
- Ticker
- AIBT
- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- State
- ID
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Jan 6, 2022
- All filings on EDGAR CIK 1763329
Other qualified Biotech & pharma Reg A offerings
- Balanced Pharma IncApr 8, 2022 · $25M
- Sibannac, Inc.Feb 7, 2022 · $9.4M
- Gelstat CorpDec 17, 2021 · $5M
- RespireRx Pharmaceuticals Inc.Dec 13, 2021 · $7.5M
- Coeptis Therapeutics Inc.Dec 3, 2021 · $12M
- Marijuana Co of America, Inc.Oct 20, 2021 · $10M